MetLife, Inc. $MET Shares Acquired by Pzena Investment Management LLC

Pzena Investment Management LLC grew its stake in MetLife, Inc. (NYSE:METFree Report) by 6.8% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,144,635 shares of the financial services provider’s stock after acquiring an additional 585,671 shares during the quarter. MetLife comprises approximately 2.4% of Pzena Investment Management LLC’s investment portfolio, making the stock its 17th biggest position. Pzena Investment Management LLC’s holdings in MetLife were worth $735,412,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. North Capital Inc. acquired a new stake in shares of MetLife in the 1st quarter worth $26,000. Motco increased its stake in shares of MetLife by 105.5% in the 1st quarter. Motco now owns 413 shares of the financial services provider’s stock worth $33,000 after acquiring an additional 212 shares during the last quarter. GFG Capital LLC acquired a new stake in shares of MetLife in the 2nd quarter worth $38,000. Abound Wealth Management increased its stake in shares of MetLife by 652.3% in the 2nd quarter. Abound Wealth Management now owns 489 shares of the financial services provider’s stock worth $39,000 after acquiring an additional 424 shares during the last quarter. Finally, Legend Financial Advisors Inc. acquired a new stake in shares of MetLife during the 2nd quarter worth about $40,000. 94.99% of the stock is owned by institutional investors and hedge funds.

MetLife Stock Performance

Shares of MetLife stock opened at $79.88 on Monday. The business has a 50-day moving average of $79.68 and a 200 day moving average of $78.08. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $89.05. The stock has a market capitalization of $53.12 billion, a price-to-earnings ratio of 13.54, a price-to-earnings-growth ratio of 0.72 and a beta of 0.86. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.16 and a quick ratio of 0.16.

MetLife (NYSE:METGet Free Report) last announced its earnings results on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing analysts’ consensus estimates of $2.32 by ($0.30). MetLife had a net margin of 5.83% and a return on equity of 19.88%. The firm had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $18.58 billion. During the same quarter last year, the business earned $2.28 earnings per share. The business’s revenue was down 2.7% compared to the same quarter last year. As a group, sell-side analysts forecast that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 4th will be paid a $0.5675 dividend. This represents a $2.27 annualized dividend and a dividend yield of 2.8%. The ex-dividend date is Tuesday, November 4th. MetLife’s dividend payout ratio (DPR) is presently 38.47%.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Barclays raised their price objective on MetLife from $93.00 to $98.00 and gave the stock an “overweight” rating in a research report on Wednesday. Wolfe Research raised MetLife to a “strong-buy” rating in a research report on Tuesday, September 16th. Weiss Ratings reissued a “buy (b)” rating on shares of MetLife in a research report on Wednesday, October 8th. Wells Fargo & Company raised their price objective on MetLife from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. raised their price objective on MetLife from $86.00 to $95.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 8th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, MetLife currently has a consensus rating of “Moderate Buy” and an average target price of $95.18.

Check Out Our Latest Research Report on MetLife

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Recommended Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.